Authors: van Maanen, C Vreeswijk, J Moonen, P Brinkhof, J de Boer-Luijtze, E Terpstra, C

Citation: C. Van Maanen et al., Differentiation and genomic and antigenic variation among fetal, respiratory, and neurological isolates from EHV1 and EHV4 infections in the Netherlands, VET Q, 22(2), 2000, pp. 88-93

Authors: Wils, J van Geuns, H Stoot, J Bergmans, M Boschma, F Bron, H Degen, J Erdkamp, F van Erp, J Haest, J Iding, R Lalisang, F de Pree, N de Rooy, C Snijders, M Schepers, J Vreeswijk, J Wals, J Werter, M Wetzels, L Smeets, J Schouten, L

Citation: J. Wils et al., Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial ofthe Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg, ANTI-CANC D, 10(3), 1999, pp. 257-261

Authors: Jacobs, JJL Folkers, E Vreeswijk, J

Citation: Jjl. Jacobs et al., Detection of varicella-zoster virus and herpes simplex virus by the polymerase chain reaction with degenerate primers, J VIROL MET, 83(1-2), 1999, pp. 155-167